Hard-to-match kidney transplant candidates who receive a treatment designed to make their bodies more accepting of incompatible organs are twice as likely to survive eight years after transplant surgery as those who stay on dialysis for years awaiting compatible organs.

A new treatment for hard-to-match kidney transplant patients is providing dramatic survival benefits.

Kidney transplant recipients who develop antibodies in response to receiving new organs can develop accelerated arteriosclerosis, or narrowing of the arteries that supply blood to the kidney.

ADDISON, Texas, April 20 /PRNewswire/ -- New guidelines to diagnose and treat antibody mediated rejection (AMR) in cardiac transplant patients will be the focus of a consensus conference today at the Hilton Chicago.

A new therapy improves transplant rates and outcomes for patients waiting for kidney transplants, said Cedars-Sinai Medical Center in Los Angeles.